Jack Nathan Medical Corp.
JNH.V
TSX
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.99M | 6.12M | 4.30M | 4.09M | 3.58M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.99M | 6.12M | 4.30M | 4.09M | 3.58M |
| Cost of Revenue | 937.30K | 938.70K | 572.80K | 735.50K | 804.30K |
| Gross Profit | 5.05M | 5.19M | 3.73M | 3.36M | 2.78M |
| SG&A Expenses | 6.66M | 6.67M | 5.91M | 5.36M | 4.30M |
| Depreciation & Amortization | 165.40K | 194.30K | 114.10K | 35.50K | 67.30K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.76M | 7.81M | 6.59M | 6.13M | 5.17M |
| Operating Income | -1.77M | -1.68M | -2.29M | -2.04M | -1.59M |
| Income Before Tax | -1.88M | -1.77M | -1.84M | -2.03M | -1.49M |
| Income Tax Expenses | 135.70K | 11.50K | -14.50K | -14.50K | -14.50K |
| Earnings from Continuing Operations | -2.02 | -1.78 | -1.22 | -1.42 | -0.88 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 5.01M | 5.25M | -5.15M | -5.35M | -4.81M |
| EBIT | -1.77M | -1.68M | -2.29M | -2.04M | -1.59M |
| EBITDA | -1.34M | -1.08M | -1.56M | -1.39M | -901.00K |
| EPS Basic | 0.06 | 0.06 | -0.06 | -0.06 | -0.06 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.02 | -0.02 | -0.01 |
| EPS Diluted | 0.06 | 0.06 | -0.06 | -0.06 | -0.06 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.02 | -0.02 | -0.01 |
| Average Basic Shares Outstanding | 348.40M | 348.40M | 346.83M | 345.22M | 342.85M |
| Average Diluted Shares Outstanding | 357.73M | 357.73M | 355.83M | 349.22M | 350.18M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |